A Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment

NCT03812835 · clinicaltrials.gov ↗
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Company decision to not conduct study and was cancelled prior to any enrollment.

Conditions

Sponsor

Pfizer